Brain metastases in patients with neuroendocrine neoplasms: Risk factors and outcome

Brain metastases (BM) are rarely reported in patients with neuroendocrine carcinoma (NEC) of nonlung origin and neuroendocrine tumors (NET) of the gastroenteropancreatic (GEP) or bronchopulmonary system.